These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22936589)

  • 1. Impact of hepatic lymph node metastasis on survival of patients with synchronous resectable or unresectable liver metastases of colorectal cancer.
    Ishibashi K; Ishida H; Ohsawa T; Okada N; Kumamoto K; Haga N
    Tech Coloproctol; 2013 Feb; 17(1):51-7. PubMed ID: 22936589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of hepatic lymph node metastasis in patients with unresectable synchronous liver metastasis of colorectal cancer.
    Ishida H; Ishibashi K; Ohsawa T; Okada N; Kumamoto K; Haga N
    Int Surg; 2011; 96(4):291-9. PubMed ID: 22808609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracapsular lymph node involvement is associated with colorectal liver metastases and impact outcome after hepatectomy for colorectal metastases.
    Suzuki H; Fujii T; Asao T; Tsutsumi S; Wada S; Araki K; Kubo N; Watanabe A; Tsukagoshi M; Kuwano H
    World J Surg; 2014 Aug; 38(8):2079-88. PubMed ID: 24615606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcome of liver resection and lymphadenectomy for hilar lymph node involvement in colorectal cancer liver metastases.
    Liu W; Yan XL; Wang K; Bao Q; Sun Y; Xing BC
    Int J Colorectal Dis; 2014 Jun; 29(6):737-45. PubMed ID: 24743847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases.
    Cardona K; Mastrodomenico P; D'Amico F; Shia J; Gönen M; Weiser MR; Paty PB; Kingham TP; Allen PJ; De Matteo RP; Fong Y; Jarnagin WR; D'Angelica MI
    Ann Surg Oncol; 2013 Jan; 20(1):148-54. PubMed ID: 22847127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic resection for synchronous hepatic metastasis from gastric cancer.
    Qiu JL; Deng MG; Li W; Zou RH; Li BK; Zheng Y; Lao XM; Zhou K; Yuan YF
    Eur J Surg Oncol; 2013 Jul; 39(7):694-700. PubMed ID: 23579173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage IV colorectal cancer.
    Thomay AA; Nagorney DM; Cohen SJ; Sigurdson ER; Truty MJ; Burtness B; Hall MJ; Chun YS
    J Gastrointest Surg; 2014 Jan; 18(1):69-74. PubMed ID: 24002765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Status of Hepatic Lymph Node Involvement in Patients with Resectable Liver Metastasis of Colorectal Cancer after Preoperative Chemotherapy].
    Ogura T; Muta Y; Hatano S; Amano K; Ishiguro T; Fukuchi M; Inokuma S; Kumagai Y; Ishibashi K; Mochiki E; Ishida H
    Gan To Kagaku Ryoho; 2018 Feb; 45(2):339-341. PubMed ID: 29483440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival.
    Nanji S; Cleary S; Ryan P; Guindi M; Selvarajah S; Al-Ali H; Grieg P; McGilvary I; Taylor B; Wei A; Moulton CA; Gallinger S
    Ann Surg Oncol; 2013 Jan; 20(1):295-304. PubMed ID: 23054102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis.
    Laurent C; Sa Cunha A; Rullier E; Smith D; Rullier A; Saric J
    J Am Coll Surg; 2004 Jun; 198(6):884-91. PubMed ID: 15194069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection of synchronous liver metastases from colorectal cancer.
    Fujita S; Akasu T; Moriya Y
    Jpn J Clin Oncol; 2000 Jan; 30(1):7-11. PubMed ID: 10770561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of preoperative and postoperative FOLFOX chemotherapies in patients with resectable colorectal liver metastasis.
    Faron M; Chirica M; Tranchard H; Balladur P; de Gramont A; Afchain P; Andre T; Paye F
    J Gastrointest Cancer; 2014 Sep; 45(3):298-306. PubMed ID: 24610400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases.
    Galizia G; Lieto E; Orditura M; Castellano P; Imperatore V; Pinto M; Zamboli A
    Arch Surg; 2008 Apr; 143(4):352-8; discussion 358. PubMed ID: 18427022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes.
    Gervaz P; Rubbia-Brandt L; Andres A; Majno P; Roth A; Morel P; Mentha G
    Ann Surg Oncol; 2010 Oct; 17(10):2714-9. PubMed ID: 20405223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful resection of metachronous para-aortic, Virchow lymph node and liver metastatic recurrence of rectal cancer.
    Takeshita N; Fukunaga T; Kimura M; Sugamoto Y; Tasaki K; Hoshino I; Ota T; Maruyama T; Tamachi T; Hosokawa T; Asai Y; Matsubara H
    World J Gastroenterol; 2015 Nov; 21(44):12722-8. PubMed ID: 26640350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors of colorectal cancer patients with synchronous liver metastasis treated with simultaneous liver and colorectal resection].
    Wang Z; Zhou ZX; Liang JW; Bai XF; Bi JJ
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):372-5. PubMed ID: 18953839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
    Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
    World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer.
    Miyanari N; Mori T; Takahashi K; Yasuno M
    Dis Colon Rectum; 2002 Nov; 45(11):1503-9. PubMed ID: 12432299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.
    Pietrantonio F; Di Bartolomeo M; Cotsoglou C; Mennitto A; Berenato R; Morano F; Coppa J; Perrone F; Iacovelli R; Milione M; Alessi A; Vaiani M; Bossi I; Ricchini F; Scotti M; Caporale M; Bajetta E; de Braud F; Mazzaferro V
    Clin Colorectal Cancer; 2017 Sep; 16(3):e191-e198. PubMed ID: 27979717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.